ALKS

Alkermes Plc (ALKS)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 4.41B
P/E Ratio
12.90
Revenue (TTM)
$ 1.51B
Volume
0
52W High
$ 36.45
52W Low
$ 25.56
Dividend Yield
0.00%
Beta
0.42

Technicals

50-Day MA
28.926
200-Day MA
30.152
52 Week High
36.45
52 Week Low
25.56

About ALKS

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Irelan.

Employees
1800
Headquarters
Dublin, Ireland
CEO
Mr. Richard F. Pops

Latest News

Environment, Social and Governance (ESG) Risk Ratings

Total ESG Risk Score
28.83
Percentile: 53.12
Environmental Risk Score
0.37
Percentile: 1
Social Risk Score
17.49
Percentile: 1
Governance Risk Score
8.71
Percentile: 1

Controversy Level

ESG data provided by Sustainalytics, Inc.

ALKS
Category Average
1Low Controversy Level
NoneSevere

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg